Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Development and validation of an individualized risk prediction model for oropharynx cancer in the US population.

Tota JE, Gillison ML, Katki HA, Kahle L, Pickard RK, Xiao W, Jiang B, Graubard BI, Chaturvedi AK.

Cancer. 2019 Aug 27. doi: 10.1002/cncr.32412. [Epub ahead of print]

PMID:
31454434
2.

Pre-transplant short telomeres are associated with high mortality risk after unrelated donor haematopoietic cell transplant for severe aplastic anaemia.

Wang Y, McReynolds LJ, Dagnall C, Katki HA, Spellman SR, Wang T, Hicks B, Freedman ND, Jones K, Lee SJ, Savage SA, Gadalla SM.

Br J Haematol. 2019 Aug 19. doi: 10.1111/bjh.16153. [Epub ahead of print]

PMID:
31426123
3.

Ischaemic heart disease and stroke mortality by specific coal type among non-smoking women with substantial indoor air pollution exposure in China.

Bassig BA, Dean Hosgood H, Shu XO, Vermeulen R, Chen BE, Katki HA, Seow WJ, Hu W, Portengen L, Ji BT, Wong JYY, Ning B, Downward GS, Li J, Yang K, Yang G, Gao YT, Xiang YB, Nagaradona T, Zheng W, Silverman DT, Huang Y, Lan Q.

Int J Epidemiol. 2019 Aug 3. pii: dyz158. doi: 10.1093/ije/dyz158. [Epub ahead of print]

PMID:
31377785
4.

Serum ghrelin and esophageal and gastric cancer in two cohorts in China.

Pritchett NR, Maziarz M, Shu XO, Kamangar F, Dawsey SM, Fan JH, Ji BT, Gao YT, Xiang YB, Qiao YL, Li H, Yang G, Wang SM, Stanczyk FZ, Chow WH, Katki HA, Zheng W, Lan Q, Freedman ND, Rothman N, Abnet CC, Murphy G.

Int J Cancer. 2019 Jul 27. doi: 10.1002/ijc.32597. [Epub ahead of print]

PMID:
31351006
5.

Contemporary Implications of U.S. Preventive Services Task Force and Risk-Based Guidelines for Lung Cancer Screening Eligibility in the United States.

Landy R, Cheung LC, Berg CD, Chaturvedi AK, Robbins HA, Katki HA.

Ann Intern Med. 2019 Sep 3;171(5):384-386. doi: 10.7326/M18-3617. Epub 2019 Jun 4. No abstract available.

PMID:
31158854
6.

Insights for Management of Ground-Glass Opacities From the National Lung Screening Trial.

Robbins HA, Katki HA, Cheung LC, Landy R, Berg CD.

J Thorac Oncol. 2019 Sep;14(9):1662-1665. doi: 10.1016/j.jtho.2019.05.012. Epub 2019 May 22.

PMID:
31125735
7.

Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocol.

Robbins HA, Callister M, Sasieni P, Quaife SL, Cheung LC, Brennan P, Katki HA, Berg CD, Baldwin D, Johansson M.

Lancet Respir Med. 2019 Aug;7(8):655-656. doi: 10.1016/S2213-2600(19)30136-5. Epub 2019 May 7. No abstract available. Erratum in: Lancet Respir Med. 2019 Jul;7(7):e22.

PMID:
31076382
8.

Quantifying risk stratification provided by diagnostic tests and risk predictions: Comparison to AUC and decision curve analysis.

Katki HA.

Stat Med. 2019 Jul 20;38(16):2943-2955. doi: 10.1002/sim.8163. Epub 2019 Apr 30.

PMID:
31037749
9.

Identification of Candidates for Longer Lung Cancer Screening Intervals Following a Negative Low-Dose Computed Tomography Result.

Robbins HA, Berg CD, Cheung LC, Chaturvedi AK, Katki HA.

J Natl Cancer Inst. 2019 Sep 1;111(9):996-999. doi: 10.1093/jnci/djz041.

PMID:
30976808
10.

Prioritized concordance index for hierarchical survival outcomes.

Cheung LC, Pan Q, Hyun N, Katki HA.

Stat Med. 2019 Jul 10;38(15):2868-2882. doi: 10.1002/sim.8157. Epub 2019 Apr 7.

PMID:
30957257
11.

Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting.

Landy R, Schiffman M, Sasieni PD, Cheung LC, Katki HA, Rydzak G, Wentzensen N, Poitras NE, Lorey T, Kinney WK, Castle PE.

Int J Cancer. 2019 Mar 12. doi: 10.1002/ijc.32268. [Epub ahead of print]

PMID:
30861114
12.

Circulating inflammation markers and colorectal adenoma risk.

Huang WY, Berndt SI, Shiels MS, Katki HA, Chaturvedi AK, Wentzensen N, Trabert B, Kemp TJ, Pinto LA, Hildesheim A, Rothman N, Purdue MP.

Carcinogenesis. 2019 Jul 6;40(6):765-770. doi: 10.1093/carcin/bgz027.

PMID:
30753331
13.

A Pragmatic Testing-Eligibility Framework for Population Mutation Screening: The Example of BRCA1/2.

Best AF, Tucker MA, Frone MN, Greene MH, Peters JA, Katki HA.

Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):293-302. doi: 10.1158/1055-9965.EPI-18-0584. Epub 2019 Jan 28.

PMID:
30692095
14.

Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results.

Castle PE, Kinney WK, Xue X, Cheung LC, Gage JC, Poitras NE, Lorey TS, Katki HA, Wentzensen N, Schiffman M.

J Natl Cancer Inst. 2018 Dec 21. doi: 10.1093/jnci/djy192. [Epub ahead of print]

PMID:
30576462
15.

Telomere Length Calibration from qPCR Measurement: Limitations of Current Method.

Wang Y, Savage SA, Alsaggaf R, Aubert G, Dagnall CL, Spellman SR, Lee SJ, Hicks B, Jones K, Katki HA, Gadalla SM.

Cells. 2018 Oct 24;7(11). pii: E183. doi: 10.3390/cells7110183.

16.

Nonparametric Adjustment for Measurement Error in Time-to-Event Data: Application to Risk Prediction Models.

Braun D, Gorfine M, Katki HA, Ziogas A, Parmigiani G.

J Am Stat Assoc. 2018;113(521):14-25. doi: 10.1080/01621459.2017.1311261. Epub 2017 Sep 14.

17.

Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening.

Katki HA, Kovalchik SA, Petito LC, Cheung LC, Jacobs E, Jemal A, Berg CD, Chaturvedi AK.

Ann Intern Med. 2018 Jul 3;169(1):10-19. doi: 10.7326/M17-2701. Epub 2018 May 15.

18.

Donor telomere length and causes of death after unrelated hematopoietic cell transplantation in patients with marrow failure.

Gadalla SM, Aubert G, Wang T, Haagenson M, Spellman SR, Wang L, Katki HA, Savage SA, Lee SJ.

Blood. 2018 May 24;131(21):2393-2398. doi: 10.1182/blood-2017-10-812735. Epub 2018 Apr 9.

19.

Applying Risk Prediction Models to Optimize Lung Cancer Screening: Current Knowledge, Challenges, and Future Directions.

Sakoda LC, Henderson LM, Caverly TJ, Wernli KJ, Katki HA.

Curr Epidemiol Rep. 2017 Dec;4(4):307-320. doi: 10.1007/s40471-017-0126-8. Epub 2017 Oct 24.

20.

Testing Positive on a Multigene Panel Does Not Suffice to Determine Disease Risks.

Katki HA, Greene MH, Achatz MI.

J Natl Cancer Inst. 2018 Aug 1;110(8):797-798. doi: 10.1093/jnci/djy008. No abstract available.

21.
22.

Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21-39 Years.

Silver MI, Gage JC, Schiffman M, Fetterman B, Poitras NE, Lorey T, Cheung LC, Katki HA, Locke A, Kinney WK, Castle PE.

Cancer Prev Res (Phila). 2018 Mar;11(3):165-170. doi: 10.1158/1940-6207.CAPR-17-0293. Epub 2018 Feb 5.

23.

Epidemiologic Evidence That Excess Body Weight Increases Risk of Cervical Cancer by Decreased Detection of Precancer.

Clarke MA, Fetterman B, Cheung LC, Wentzensen N, Gage JC, Katki HA, Befano B, Demarco M, Schussler J, Kinney WK, Raine-Bennett TR, Lorey TS, Poitras NE, Castle PE, Schiffman M.

J Clin Oncol. 2018 Apr 20;36(12):1184-1191. doi: 10.1200/JCO.2017.75.3442. Epub 2018 Jan 22.

24.

Preventing Lung Cancer Mortality by Computed Tomography Screening: The Effect of Risk-Based Versus U.S. Preventive Services Task Force Eligibility Criteria, 2005-2015.

Cheung LC, Katki HA, Chaturvedi AK, Jemal A, Berg CD.

Ann Intern Med. 2018 Feb 6;168(3):229-232. doi: 10.7326/M17-2067. Epub 2018 Jan 2. No abstract available.

PMID:
29297008
25.

Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-records.

Landy R, Cheung LC, Schiffman M, Gage JC, Hyun N, Wentzensen N, Kinney WK, Castle PE, Fetterman B, Poitras NE, Lorey T, Sasieni PD, Katki HA.

Prev Med. 2018 Jun;111:429-435. doi: 10.1016/j.ypmed.2017.12.004. Epub 2017 Dec 6.

26.

Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer: An Observational Cohort Study.

Castle PE, Kinney WK, Xue X, Cheung LC, Gage JC, Zhao FH, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Katki HA, Schiffman M.

Ann Intern Med. 2018 Jan 2;168(1):20-29. doi: 10.7326/M17-1609. Epub 2017 Nov 28.

PMID:
29181509
27.

Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.

Schiffman M, Kinney WK, Cheung LC, Gage JC, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Befano B, Schussler J, Katki HA, Castle PE.

J Natl Cancer Inst. 2018 May 1;110(5):501-508. doi: 10.1093/jnci/djx225.

28.

Is the Women's Health Initiative (WHI) Dietary Modification Associated With a Reduced Risk of Pancreatic Cancer?

Stolzenberg-Solomon RZ, Katki HA.

J Natl Cancer Inst. 2018 Jan 1;110(1). doi: 10.1093/jnci/djx139. No abstract available.

29.

Potential Impact of Including Time to First Cigarette in Risk Models for Selecting Ever-Smokers for Lung Cancer Screening.

Gu F, Cheung LC, Freedman ND, Katki HA, Caporaso NE.

J Thorac Oncol. 2017 Nov;12(11):1646-1653. doi: 10.1016/j.jtho.2017.08.001. Epub 2017 Aug 14.

30.

Associations between self-reported diabetes and 78 circulating markers of inflammation, immunity, and metabolism among adults in the United States.

Van Dyke AL, Lang Kuhs KA, Shiels MS, Koshiol J, Trabert B, Loftfield E, Purdue MP, Wentzensen N, Pfeiffer RM, Katki HA, Hildesheim A, Kemp TJ, Pinto LA, Chaturvedi AK, Safaeian M.

PLoS One. 2017 Jul 28;12(7):e0182359. doi: 10.1371/journal.pone.0182359. eCollection 2017.

31.

Mixture models for undiagnosed prevalent disease and interval-censored incident disease: applications to a cohort assembled from electronic health records.

Cheung LC, Pan Q, Hyun N, Schiffman M, Fetterman B, Castle PE, Lorey T, Katki HA.

Stat Med. 2017 Sep 30;36(22):3583-3595. doi: 10.1002/sim.7380. Epub 2017 Jun 28.

32.

Why does cervical cancer occur in a state-of-the-art screening program?

Castle PE, Kinney WK, Cheung LC, Gage JC, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Befano B, Schussler J, Katki HA, Schiffman M.

Gynecol Oncol. 2017 Sep;146(3):546-553. doi: 10.1016/j.ygyno.2017.06.003. Epub 2017 Jun 10.

33.

FLEXIBLE RISK PREDICTION MODELS FOR LEFT OR INTERVAL-CENSORED DATA FROM ELECTRONIC HEALTH RECORDS.

Hyun N, Cheung LC, Pan Q, Schiffman M, Katki HA.

Ann Appl Stat. 2017 Jun;11(2):1063-1084. doi: 10.1214/17-AOAS1036. Epub 2017 Jul 20.

34.

Sleep Duration across the Adult Lifecourse and Risk of Lung Cancer Mortality: A Cohort Study in Xuanwei, China.

Wong JY, Bassig BA, Vermeulen R, Hu W, Ning B, Seow WJ, Ji BT, Downward GS, Katki HA, Barone-Adesi F, Rothman N, Chapman RS, Lan Q.

Cancer Prev Res (Phila). 2017 Jun;10(6):327-336. doi: 10.1158/1940-6207.CAPR-16-0295. Epub 2017 Apr 4.

35.

Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.

Kreimer AR, Johansson M, Yanik EL, Katki HA, Check DP, Lang Kuhs KA, Willhauck-Fleckenstein M, Holzinger D, Hildesheim A, Pfeiffer R, Williams C, Freedman ND, Huang WY, Purdue MP, Michel A, Pawlita M, Brennan P, Waterboer T.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djx005.

36.

Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines.

Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LA, Myers O, Cuzick J, Wentzensen N, Kinney W, Castle PE, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

Obstet Gynecol. 2016 Dec;128(6):1248-1257.

37.

Proof-of-principle study of a novel cervical screening and triage strategy: Computer-analyzed cytology to decide which HPV-positive women are likely to have ≥CIN2.

Schiffman M, Yu K, Zuna R, Terence Dunn S, Zhang H, Walker J, Gold M, Hyun N, Rydzak G, Katki HA, Wentzensen N.

Int J Cancer. 2017 Feb 1;140(3):718-725. doi: 10.1002/ijc.30456. Epub 2016 Oct 17.

38.

Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia.

Gadalla SM, Wang T, Dagnall C, Haagenson M, Spellman SR, Hicks B, Jones K, Katki HA, Lee SJ, Savage SA.

Biol Blood Marrow Transplant. 2016 Dec;22(12):2276-2282. doi: 10.1016/j.bbmt.2016.09.012. Epub 2016 Sep 15.

39.

Burden of HPV-positive oropharynx cancers among ever and never smokers in the U.S. population.

Chaturvedi AK, D'Souza G, Gillison ML, Katki HA.

Oral Oncol. 2016 Sep;60:61-7. doi: 10.1016/j.oraloncology.2016.06.006. Epub 2016 Jul 8.

PMID:
27531874
40.

The limitations of qPCR telomere length measurement in diagnosing dyskeratosis congenita.

Gadalla SM, Khincha PP, Katki HA, Giri N, Wong JY, Spellman S, Yanovski JA, Han JC, De Vivo I, Alter BP, Savage SA.

Mol Genet Genomic Med. 2016 Mar 20;4(4):475-9. doi: 10.1002/mgg3.220. eCollection 2016 Jul.

41.

Screening: A risk-based framework to decide who benefits from screening.

Castle PE, Katki HA.

Nat Rev Clin Oncol. 2016 Sep;13(9):531-2. doi: 10.1038/nrclinonc.2016.101. Epub 2016 Jun 21. No abstract available.

42.

Reply to Letter: Using novel risk stratification statistics to better understand the value of screening tests.

Katki HA, Zhao FH, Hu SY, Zhang Q, Qiao YL, Schiffman M.

Int J Cancer. 2016 Oct 1;139(7):1669. doi: 10.1002/ijc.30192. Epub 2016 Jun 5. No abstract available.

43.

Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.

Katki HA, Kovalchik SA, Berg CD, Cheung LC, Chaturvedi AK.

JAMA. 2016 Jun 7;315(21):2300-11. doi: 10.1001/jama.2016.6255.

44.

Cancer risk among the HIV-infected elderly in the United States.

Yanik EL, Katki HA, Engels EA.

AIDS. 2016 Jun 19;30(10):1663-8. doi: 10.1097/QAD.0000000000001077.

45.

Risk assessment to guide cervical screening strategies in a large Chinese population.

Zhao FH, Hu SY, Zhang Q, Zhang X, Pan QJ, Zhang WH, Gage JC, Wentzensen N, Castle PE, Qiao YL, Katki HA, Schiffman M.

Int J Cancer. 2016 Jun 1;138(11):2639-47. doi: 10.1002/ijc.30012. Epub 2016 Feb 4.

46.

A joint model of persistent human papillomavirus infection and cervical cancer risk: Implications for cervical cancer screening.

Katki HA, Cheung LC, Fetterman B, Castle PE, Sundaram R.

J R Stat Soc Ser A Stat Soc. 2015 Oct 1;178(4):903-923. Epub 2015 Mar 17.

47.

Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program.

Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LC, Cuzick J, Myers O, Castle PE, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):36-42. doi: 10.1158/1055-9965.EPI-15-0669. Epub 2015 Oct 30.

48.

Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.

Shiels MS, Katki HA, Hildesheim A, Pfeiffer RM, Engels EA, Williams M, Kemp TJ, Caporaso NE, Pinto LA, Chaturvedi AK.

J Natl Cancer Inst. 2015 Jul 28;107(10). pii: djv199. doi: 10.1093/jnci/djv199. Print 2015 Oct.

49.

Leukoplakia, Oral Cavity Cancer Risk, and Cancer Survival in the U.S. Elderly.

Yanik EL, Katki HA, Silverberg MJ, Manos MM, Engels EA, Chaturvedi AK.

Cancer Prev Res (Phila). 2015 Sep;8(9):857-63. doi: 10.1158/1940-6207.CAPR-15-0091. Epub 2015 Jul 9.

50.

A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results.

Schiffman M, Vaughan LM, Raine-Bennett TR, Castle PE, Katki HA, Gage JC, Fetterman B, Befano B, Wentzensen N.

Gynecol Oncol. 2015 Sep;138(3):573-8. doi: 10.1016/j.ygyno.2015.06.040. Epub 2015 Jul 4.

Supplemental Content

Loading ...
Support Center